PubMed:33754144 / 893-1057 JSONTXT

Annnotations TAB JSON ListView MergeView

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":164},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":164},"obj":"Sentence"}],"text":"Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo."}

    yangbin123xm_800_3

    {"project":"yangbin123xm_800_3","denotations":[{"id":"T5","span":{"begin":98,"end":110},"obj":"CI"},{"id":"T10","span":{"begin":156,"end":163},"obj":"CI"}],"text":"Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo."}

    chenxin_473849_800_3

    {"project":"chenxin_473849_800_3","denotations":[{"id":"T11","span":{"begin":156,"end":163},"obj":"CI"},{"id":"T6","span":{"begin":98,"end":110},"obj":"CI"}],"text":"Patients were randomly assigned (1:1) centrally, with stratification by hospital site, to receive mavrilimumab 6 mg/kg as a single intravenous infusion, or placebo."}